7600 — Japan Medical Dynamic Marketing Income Statement
0.000.00%
- ¥13bn
- ¥16bn
- ¥25bn
- 51
- 52
- 27
- 37
Annual income statement for Japan Medical Dynamic Marketing, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16,738 | 19,193 | 21,308 | 23,178 | 25,114 |
| Cost of Revenue | |||||
| Gross Profit | 11,418 | 12,989 | 13,993 | 14,762 | 15,647 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 14,660 | 16,373 | 19,557 | 21,637 | 25,389 |
| Operating Profit | 2,078 | 2,820 | 1,751 | 1,541 | -275 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 2,034 | 2,750 | 1,770 | 1,637 | -342 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,681 | 2,142 | 1,436 | 1,305 | -469 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1,665 | 2,136 | 1,424 | 1,272 | -462 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,665 | 2,136 | 1,424 | 1,272 | -462 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 65.9 | 76.3 | 62.5 | 54.6 | 27.7 |
| Dividends per Share |